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ABSTRACT
Neuromyelitis optica (NMO) also known as Devic’s disease is an acute demyelinating disorder combined with optic
neuritis and transverse myelitis.A 10 years old boy presented in the ER with the complaints of fever and back pain for
past 10 days and inability to walk for 6-7 days. He had developed urinary retention and constipation for the past 5
days along with abdominal distension. There was also blurring of vision in the left eye with only light perception and
rapid afferent papillary defect was present while the right eye was normal. The provisional diagnosis was Transverse
myelitis vsNeuromyelitisoptica (NMO). CSF revealed TLC 4, protein 54mg/dl, glucose 66mg/dl. Oligoclonal bands were
negative. There was raised CPK. Visual evoked potential (VEP) showed prolongation of P100 latency along with
amplitude loss, in left eye.His MRI spine showed extensive involvement of the spinal cord especially the cervical cord
and there was no involvement of the brain. Left eye had optic neuritis.He was treated with steroid pulse therapy and
later Plasmapharesis and was discharged home on azathioprine with no motor deficit but the visual loss was
irreversible
KEY WORDS: optic neuritis, myelitis, Devic’s disease
INTRODUCTION

where he was catheterized and started on broad
spectrum antibiotics for the past 4 days but there was
no improvement they came to this hospital.
His birth and development was normal and he was a
student of class III. There was no history of any
allergies or surgery. Immunization was up to date.
Family history included two sisters and three brothers
who were well and healthy. There was no family history
for any neurological disease or unexplained visual loss.
On examination the patient was fully alert, interactive
and oriented. His anthropometric measures were on
the 50th centile. He was afebrile, with stable vitals.
There was no rash or lymphadenopathy. He was well
hydrated and well nourished. His chest was clear with
normal vesicular breathing while abdomen was full with
slit like umbilicus and urinary bladder was palpable at
the level of umbilicus, there was no shifting dullness or
visceromegaly and gut sounds were audible. His GCS
was 15/15 and higher mental functions were intact.
Cranial nerves were intact. Tone was normal in all four
limbs; power was 4/5 in both upper limbs and 1/5 in
lower limbs. Deep tendon reflexes in upper limbs were
+2 and in lower limbs +3. Planters were up going.
Superficial reflexes were absent. On sensory
examination pain, temperature, vibration and
proprioception were intact. There were no signs of
meningeal irritation. He was unable to sit and

Neuromyelitis optica (NMO) also known as Devic’s
disease is an acute demyelinating disorder comprising
of optic neuritis and transverse myelitis.1 NMO
predominantly affects middle aged adults, while case
reports from the pediatric population have been
increasing in past few years. A recent case series of
pediatric NMO revealed strong female predominance2.
NMO has specific diagnostic criteria and unique
pathologic features when compared with multiple
sclerosis (MS) 3. Pediatric NMO has comparatively
poor visual and motor outcomes.1Traditionally, the
term NMO was applied to those patients who
experienced a monophasic event consisting of bilateral
simultaneous optic neuritis and acute myelitis.4
CASE REPORT
A 10 years old boy presented in the ER with the
complaints of fever and back pain for past 10 days and
inability to walk for 6-7 days. He had developed urinary
retention and constipation for the past 5 days along
with abdominal distension. For the past two days he
had been complaining of blurring of vision in the left
eye. There was no history of any recent viral illness,
vaccination or trauma. He had been to a hospital
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complained of pain on movement. His left eye had only
light perception and showed rapid afferent papillary
defect
while
the
right
eye
was
normal
The provisional diagnosis was Transverse myelitis
vsNeuromyelitisoptica (NMO). Complete blood count
and basic metabolic workup was normal. Inflammatory
markers (C- reactive proteins and Erythrocyte
sedimentation rate) were within normal limits. CSF
revealed TLC 4, protein 54mg/dl, glucose 66mg/dl.
Oligoclonal bands were negative. There was raised
CPK. Visual evoked potential (VEP) showed
prolongation of P100 latency along with amplitude
loss, in left eye.MRI revealed multiple abnormal T2
hyper intense signals showing post contrast
enhancement almost along the entire spinal cord.
These were predominately identified in the cervical
region of the spinal cord along with swelling of the cord
in this region. Overall appearance was suggestive of
transverse myelitis. Bilateral globes and optic nerve
appeared unremarkable. The grey matter and white
matter appeared normalA diagnosis of Devic's disease
was made and the patient was treated initially with
intravenous methyl prednisolone (30 mg/kg/day for five
days) followed by gradually tapered oral steroids.
Condition of child remained static; therefore
Plasmapharesis was done for 5 days. Azathioprine 2
mg/kg/day was added and limb physiotherapy started.
Clinical outcome was favorable with significant
reversible of power and function of limbs.

common finding at the onset of NMO, so on follow-up
scans must be performed periodically for development
of later lesions in the course of the disease.4 Lesions
in the Spinal cord are large, and extends over three or
more vertebral segments in about 85-90% of patients
and are mostly located in the cervical and upper
thoracic region. The Current revised diagnostic criteria
of NMO tells the presence of acute optic neuritis and
myelitis with at least two of the three supportive
criteria, which consist of spinal cord MRI lesion
extending over three consecutive vertebral segments,
brain MRI lesion, which does not meet the diagnostic
criteria for multiple sclerosis, and NMO-IgG
seropositive status.Our patient had no systemic
disorder or non-organ-specific autoimmune disorder or
autoantibody. At the time of the left eye's involvement,
our patient fulfilled the diagnostic criteria.7 CSF
examination of our patient showed no pleocytosis.
Oligoclonal bands of IgG in the CSF are frequently seen
in MS and these are detected in 15-30% of patients
with NMO.8 Oligoclonal bands were negative in our
patient's CSF examination.A number of modalities
have been tried but there is no proven treatment
protocol as yet either in the acute attacks or in the long
term remissions in NMO. Hence Intravenous
corticosteroid therapy is the commonly preferred initial
treatment for acute attacks.7 A total of 50% of the
patients, those who are unresponsive to corticosteroid
treatment may benefit from plasmapheresis.7 The
efficacy
of
immunomodulatory
therapies
(Beta-interferon) have not been proven yet. However,
immunosuppressive therapy (oral azathioprine,
associated with or without oral steroids; intravenous
immunoglobulin; Rituximab) is an accepted method to
provide clinical remission of corticosteroid resistant
NMO.9Our patient received both steroid pulse therapy
and Plasmapharesis and was sent home on oral
steroids and azathioprine. He became fully mobile with
no neurological deficit in the lower limbs though his
vision
was
lost
in
the
left
eye

Discussion
By definition NMO is a monophasic or relapsing
disorder of the optic nerves and the spinal cord,
without evidence of white matter dysfunction of the
brain, brainstem or cerebellum, with the exception of
hypothalamic and lower brainstem dysfunction. Optic
nerve and spinal cord dysfunction might be partial and
it can be unilateral or even subclinical, with an
abnormal visual evoked potential but no clinical signs.
Partial forms of NMO are also called high-risk NMO, in
which isolated transverse myelitis or optic neuritis
occurs. The optico-spinal form of MS is quite similar to
NMO. Hence, it appears to be a spectrum of NMO, with
various degrees of involvement but course of NMO is
more acute, sometimes fulminant. In contrastwith the
optic neuritis of MS, NMO optic neuritis can be severe,
fulminant and devastating with very poor
prognosis.5Brain lesions have been observed in
children; in one series 68% of NMO-IgG seropositive
children and among them 45% had brain symptoms
which corresponding to the MRI abnormalities6. In
contrast to MS, attacks in NMO commonly spare the
brain in the early stages. Hence, normal brain MRI is a
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Conclusion
NMO is a rare but severe devastating disease affecting
vision and nervous system resulting in blindness and
paraplegia in children. Hence an early intervention with
the appropriate treatment modality in patients
suspected with NMO decides on the favorable
outcome from an acute episode

28

VOL. 11 (2) APR

-

JUN

2016

Fig. 1b
Fig. 1a

Fig 1a and b: Abnormal T2 hyper intense signals
showing post contrast enhancement predominantly
in the cervical region along with swelling of the cord

Fig. 2b
Fig. 2a

Fig 2a and b: The entire spine shows post contrast
enhancement with marked hyper intense signals in
the cervical cord

Fig. 3

Fig 3. Shows transverse section of the cervical spine with hyper
intensities more marked posteriorly as compared to anterior cord
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